This study is a prospective observational study in which a female patient who received IV Artesunate while pregnant can volunteer to provide information about her pregnancy and the outcome of her pregnancy. Information will be collected from patient's provider, the patient's obstetrician, the child's pediatrician, or other relevant healthcare provider.
Pregnancy, Malaria
This study is a prospective observational study in which a female patient who received IV Artesunate while pregnant can volunteer to provide information about her pregnancy and the outcome of her pregnancy. Information will be collected from patient's provider, the patient's obstetrician, the child's pediatrician, or other relevant healthcare provider.
Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants
-
4C Pharma Solutions, Piscataway, New Jersey, United States, 08854
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
15 Years to 100 Years
FEMALE
No
Amivas (US), LLC,
Bryan Smith, MD, PRINCIPAL_INVESTIGATOR, Amivas (US), LLC
2029-07-01